Effect of Rosmarinus officinalis on Mental Disorder Symptoms in Incarcerated People and Prison Workers
Shirlei Sztormowski
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil and Uri Santiago, Brazil.
Karine Raquel Uhdich Kleibert
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil.
Greissi Tatieli Franke Tremêa
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil.
Simony Costa Beber
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil.
Lenara Schalanski Krause
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil.
José Antonio Gonzalez da Silva
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil.
Christiane de Fátima Colet *
Regional University of the Northwest of the State of Rio Grande do Sul – UNIJUÍ, Brazil.
*Author to whom correspondence should be addressed.
Abstract
Introduction: common mental disorders whose symptoms are not early identified can turn into more serious illnesses, such as depression, anxiety, and mood disorder. The literature presents the use of rosemary as a form of treatment of physical and mental illnesses, including depression.
Objective: The objective of this study was to evaluate the effects of treatments with different doses of rosemary (Rosmarinus officinalis) extract on symptoms of Common Mental Disorders (CMD) in incarcerated people and prison workers.
Methods: This is a randomized, double-blind, placebo-controlled clinical trial study. The intervention was carried out using rosemary extract doses at 100, 500, and 1000 mg day-1 in groups composed of 10 participants, for 3 months. A 20-item self-reporting questionnaire (SRQ-20) was used to assess the presence of CMD. The project was submitted and approved by the Research Ethics Committee under the number 4,973,589.
Results: The treatments with rosemary extract at 500 and 1000 mg day-1 showed statistically significant results for reducing CMD symptoms when compared to the those found at the beginning of the research.
Conclusion: The use of rosemary extract was effective to reduce CMD in the evaluated prison staff and incarcerated people, especially when used at doses of 500 and 1000 mg day-1, and presented safety, as the participants did not experience side effects.
Keywords: Rosemary, mental health, incarcerated persons
How to Cite
References
Lucchese R, Silva PCD, Denardi TC, Felipe RL de, Vera I, Castro PA et al. Common mental disorder among individuals who abuse alcohol and drug: a cross-sectional study. Text context - enferm [Internet]. 2017 [cited June 16, 2022];26.
Available:http://www.scielo.br/j/tce/a/FckbfnPvfBFCXXkh4q8Lstz/abstract/?lang=pt
Goldberg D, Huxley P. Common mental disorders: a bio-social model. London: Travistock; 1992.
Nóbrega M do PS de S, Fernandes MFT, Silva P de F. Application of the therapeutic relationship to people with common mental disorders. Rev Gaúcha Enferm [Internet]. 2017 [cited June 16, 2022];38.
Available:http://www.scielo.br/j/rgenf/a/GFvJSxMsSKrZwtcvR8PZtzB/abstract/?lang=pt
Jacinto A, Tolfo S da R. Psychosocial risk factors at work and Common Mental Disorder: a systematic review of studies that used the JCQ, JSS and SRQ-20 instruments. IMED Psychology Journal. 2017;9(2):107–24.
WHO. ICD 10: international statistical classification of diseases and health-related problems. São Paulo: World Health Organization. 2010;1200.
Chaves SC da S, Nobrega M do PS de S, Silva T dos S. Non-pharmacological interventions offered to users with common mental disorders in primary health care. Journal of Nursing and Health [Internet]. 2019 [cited June 16, 2022];9(3).
Available:https://periodicos.ufpel.edu.br/ojs2/index.php/enfermagem/article/view/14472
Duke JA. The garden pharmacy. Rosemary, the Herb of Remembrance for Alzheimer's. Alternative and Complementary Therapies [Internet]. 2007;13(6).
Available:https://www.liebertpub.com/doi/abs/10.1089/act.2007.13603?journalCode=act
Franco IJ, Fontana VL. Herbs & plants. The medicine of the simple. 11th ed. Edelbra; 2007.
Heinrich M, Kufer J, Leonti M, Pardo-de-Santayana M. Ethnobotany and ethnopharmacology—Interdisciplinary links with the historical sciences. Journal of Ethnopharmacology. 2006;107(2):157– 60.
Blacks P. A-Z Guide to Plants: Spices. São Paulo: Bei communication; 2003.
Takeda H, Tsuji M, Miyamoto J, Matsumiya T. Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress. Psychopharmacology. 2002; 164(2):233–5.
Machado DG, Bettio LEB, Cunha MP, Capra JC, Dalmarco JB, Pizzolatti MG, et al. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009;33(4):642–50.
Medeiros-Costa ME, Maciel RH, Fernandes Gurgel F, Medeiros-Costa ME, Maciel RH, Fernandes Gurgel F. Common mental disorders and burnout syndrome in prison officers. Science & Amp; work. 2018;20(61):36–41.
Farias N, Buchalla CM. The International Classification of Functioning, Disability and Health of the World Health Organization: concepts, uses and perspectives. Rev Bras Epidemiol. June 2005;8(2):187–93.
Amaral SMS do, Blatt CR. Inter-municipal consortium for the acquisition of medicines: impact on shortages and cost. Rev Public Health. August 2011;45(4): 799–801.
VM file. Evaluation of the antidepressant and anxiolytic activity of the essential oil of Rosmarinus officinalis L. [Dissertation (Master in Biological Sciences)]. [Botucatu]: State University of São Paulo; 2010.
Dalmarco JB. Study of the chemical and biological properties of Rosmarinus officinalis L. [Thesis (Doctorate in Chemistry)]. [Florianopolis]: Federal University of Santa Catarina; 2012.
Nematolahi P, Mehrabani M, Karami-Mohajeri S, Dabaghzadeh F. Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. Complementary Therapies in Clinical Practice. 2018;30:24–8.
Stasi LCD. Medicinal plants; Art and science. An Interdisciplinary Study Guide. São Paulo: UNESP; 1996.
Ribeiro DS, Melo DB, Guimaraes AG, Velozo ES. Evaluation of rosemary essential oil (Rosmarinus officinalis L.) as a modulator of bacterial resistance. Without Ci Agr. 2012;33(2):687–96.
Ferlemi AV, Katsikoudi A, Kontogianni VG, Kellici TF, Iatrou G, Lamari FN, et al. Rosemary tea consumption results to anxiolytic- and anti-depressant-like behavior of adult male mice and inhibits all cerebral area and liver cholinesterase activity; phytochemical investigation and in silico studies. Chemico-Biological Interactions. 2015;237:47–57.